Saenz EV, Golibkhon A, Ibragim Y. A Comprehensive Analysis of Visfatin Drug in Type 2 Diabetes, Insulin Resistance, and Cardiovascular Disease. Journal of Prevention, Diagnosis and Management of Human Diseases [Internet]. 2023 Jun. 29 [cited 2025 Sep. 1];3(04):9-17. Available from: https://journal.hmjournals.com/index.php/JPDMHD/article/view/2366